Virological aspects of non-human primates or swine-to human xenotransplantation
DOI:
https://doi.org/10.1515/fobio-2017-0008Keywords:
PERV, HIV, zoonoses, transgenic animalsAbstract
There are a number of human diseases, which can lead to organ failure. The consequence is often the need for a transplant. The number of performed operations is very low due to the shortage of organs for transplantation. As a consequence, the number of people waiting for transplant is still growing. The solution to this situation may be xenotransplantation. Xenotransplantation word comes from the Greek xenos meaning stranger, the other. It is defined as any procedure that involves the transplantation, implantation or infusion of tissues or zoonotic organs into a human recipient, but also human body fluids, cells, tissues, organs (or fragments) that have ex vivo contact with zoonotic cells, tissues or organs. One of the obstacles of the xenograft transplantation is the risk of animal pathogens transmission to the humans. Viruses that pose risk in the non-human primates-to-human xenotransplantation includes: the human immunodeficiency virus - HIV and the Marburg virus described in this paper. In addition viruses, which is a problem in pig-to-human xenotransplantation have also been described, including: porcine endogenous retrovirus - PERV, porcine cytomegalovirus - PCMV, porcine lymphotropic herpesvirus - PLHV and hepatitis E virus - E - HEV. This review of literature is the latest knowledge of the microbiological safety of xenotransplantation.
Downloads
References
Banks, M., Bendall, R., Grierson, S., Heath, G., Mitchell, J., Dalton, H. 2004. Human and porcine hepatitis E virus strains, United Kingdom. Emerging Infectious Diseases, 10 (5): 953–955.
Google Scholar
Boneva, R., Folks, T., Chapman, L. 2001. Infectious disease issues in xenotransplantation. Clinical Microbiology Reviews, 14 (1): 1–14.
Google Scholar
Cooper, D.K.C., Ekser, B., Tector, J. 2015. A brief history of clinical xenotransplantation. International Journal of Surgery, 23: 205–210.
Google Scholar
Dieckhoff, B., Petersen, B., Kues, W.A., Kurth, R., Niemann, H., Denner, J. 2008. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-Specific shRNA in transgenic pigs. Xenotransplantation, 15 (1): 36–45.
Google Scholar
Dörrschuck, E., Münk, C., Tönjes, R.R. 2008. APOBEC3 proteins and porcine endogenous retroviruses. Transplantation Proceedings, 40 (4): 959–961.
Google Scholar
Fischer, K., Kraner-Scheiber, S., Petersen, B., Rieblinger, B., Buermann, A., Flisikowska, T., Flisikowski, K., Christan, S., Edlinger, M., Baars, W., Kurome, M., Zakhartchenko, V., Kessler, B., Plotzki, E., Szczerbal, I., Switonski, M., Denner, J., Wolf, E., Schwinzer, R., Niemann, H., Kind, A. Schnieke, A. 2016. Efficient production of multi-modified pigs for xenotransplantation by ‘combineering’, gene stacking and gene editing. Nature Scientific Reports, 6: 29081.
Google Scholar
Fujita, F., Yamashita-Futsuki, I., Eguchi, S., Kamohara, Y., Fujioka, H., Yanaga, K., Furui, J., Moriuchi, R., Kanematsu, T., Katamine. S. 2003. Inactivation of porcine endogenous retrovirus by human serum as a function of complement activated through the classical pathway. Hepatology Research : The Official Journal of the Japan Society of Hepatology, 26 (2): 106–113.
Google Scholar
Gazda, L. S., Collins, J., Lovatt, A., Holdcraft, R.W., Morin, M.J., Galbraith, D., Graham, M. Laramore, M.A., Maclean, C., Black, J., Milne, E.W., Marthaler, D.G., Vinerean, H.V., Michalak, M.M., Hoffer, D., Richter, S., Hall, R.D., Smith, B.H. 2016. A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials. Xenotransplantation, 23 (6): 444–463.
Google Scholar
Gollackner, B., Mueller, N.J., Houser, S., Qawi, I., Soizic, D., Knosalla, C., Buhler, L., Dor, F.J., Awwad, M., Sachs, D.H., Cooper, D.K., Robson, S.C., Fishman, J.A. 2003. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation, 75 (11): 1841–1847.
Google Scholar
Gołąb, J., Basak, G.W. 2012. Immunologia. Wydawnictwo Naukowe PWN, Warszawa.
Google Scholar
Günzburg, W.H., Salmons, B. 2000. Xenotransplantation: is the risk of viral infection as great as we thought? Molecular Medicine Today, 6 (5): 199–208.
Google Scholar
Jura, J., Słomski, R., Gajda, B., Wieczorek, J., Lipiński, D., Kalak, R., Juzwa, W., Zeyland, J. 2006. Uzyskiwanie świń wykorzystywanych w ksenotransplantacji. Biotechnologia, 1 (72): 151–158.
Google Scholar
Kuwaki, K., Tseng, Y.-L., Dor, F.J.M.F., Shimizu, A., Houser, S.L., Sanderson, T.M., Lancos, C.J., Prabharasuth, D.D., Cheng, J., Moran, K., Hisashi, Y., Mueller, N., Yamada, K., Greenstein, J.L., Hawley, R.J., Patience, C., Awwad, M., Fishman, J.A., Robson, S.C., Schuurman, H.J., Sachs, D.H., Cooper, D.K. 2005. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nature Medicine, 11 (1): 29–31.
Google Scholar
Morozov, V.A., Plotzki, E., Rotem, A., Barkai, U., Denner, J. 2016. Extended microbiological characterization of göttingen minipigs: porcine cytomegalovirus and other viruses. Xenotransplantation, 23 (6): 490–496.
Google Scholar
Morozov, V.A, Heinrichs, G., Denner, J. 2017. Effective detection of porcine cytomegalovirus using non-invasively taken samples from piglets. Viruses, 9 (1): 1–14.
Google Scholar
Onions, D., Cooper, D.K., Alexander, T.J., Brown, C., Claassen, E., Foweraker, J.E., Harris, D.L., Mahy, B.W., Minor, P.D., Osterhaus, A.D., Pastoret, P.P., Yamanouchi, K. 2000. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation, 7 (2): 143–155.
Google Scholar
Plotzki, E., Wolf-van Buerck, L., Knauf, Y., Becker, T., Maetz-Rensing, K., Schuster, M., Baehr, A., Klymiuk, N., Wolf, E., Seissler, J., Denner, J. 2015. Virus safety of islet cell transplantation from transgenic pigs to marmosets. Virus Research, 204: 95–102.
Google Scholar
Plotzki, E., Keller, M., Ehlers, B., Denner, J. 2016. Immunological methods for the detection of porcine lymphotropic herpesviruses (PLHV). Journal of Virological Methods, 233: 72–77.
Google Scholar
Rumbwere, D., Benhildah, N., Marshall, T.P., Ryan, R.P. 2016. Predictors of human immunodeficiency virus (HIV) infection in primary care: a systematic review protocol. Systematic Reviews, 5 (1): 158.
Google Scholar
Santoni, F., Lindner, I., Caselli, E., Goltz, M., Di Luca, D., Ehlers, B. 2006. Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts? Xenotransplantation, 13 (4): 308–317.
Google Scholar
Saxena, R., Khan, F., Masood, M., Qureshi, Z., Rathore, M. 2016. Review on transplantation: a social medical need. Journal of Critical Reviews, 3 (2): 1–7.
Google Scholar
Scobie, L., Takeuchi, Y. 2009. Porcine endogenous retrovirus and other viruses in xenotransplantation. Current Opinion in Organ Transplantation, 14: 175–179.
Google Scholar
Smorąg, Z., Słomski, R., Jura, J., Lipiński, D., Skrzyszowska, M. 2011. Transgeniczne świnie jako dawcy tkanek i narządów do transplantacji U Ludzi. Przegląd hodowlany, 11:1–4.
Google Scholar
Specke, V., Schuurman, H.J., Plesker, R., Coulibaly, C., Ozel, M., Langford, G., Kurth, R., Denner, J. 2002. Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transplant Immunology, 9 (2–4): 281–288.
Google Scholar
Wilson, C.A. 2008. Porcine endogenous retroviruses and xenotransplantation. Cellular and Molecular Life Sciences, 65 (21): 3399–3412.
Google Scholar
Yang, L., Guell, M., Niu, D., George, H., Lesha, E., Grishin, D., Aach, J., Shrock E., Xu, W., Poci, J., Cortazio, R., Wilkinson, R.A., Fishman, J.A., Church, G. 2015. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science, 350 (6264): 1101–1104.
Google Scholar
Zeyland, J., Lipiński, D., Słomski, R. 2015. The current state of xenotransplantation.” Journal of Applied Genetics 56 (2): 211–218.
Google Scholar
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.